The Efficacy of Ticagrelor on Abdominal Aortic Aneurysm (AAA) Expansion

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 145 participants.

Also called NCT02070653

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 145 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02070653
Other papers using this trial's data
  • The effect of ticagrelor on growth of small abdominal aortic aneurysms-a randomized controlled trial Cardiovascular research, 2020-02-01 DOI, PubMed 31135888

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Sweden (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02070653. Randomized; quadruple masking; primary purpose treatment. Start 2014-03 (actual); primary completion 2016-07 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The Efficacy of Ticagrelor on Abdominal Aortic Aneurysm (AAA) Expansion
Acronym
TicAAA
Condition
Abdominal Aortic Aneurysm
Intervention (Drug)
Ticagrelor
Intervention (Drug)
Placebo
Lead sponsor
Uppsala University (class: other)
Collaborator
AstraZeneca (class: industry)

Record details

Record id
cardio:ct-nct02070653
Content hash
d90e5e68d9b1c5756b20566948d9e330cd7beafbd434c574f6298d02e436216c